The use of local anaesthetic (Lignocaine) in fine needle biopsy of thyroid nodules

ISRCTN ISRCTN48936612
DOI https://doi.org/10.1186/ISRCTN48936612
Secondary identifying numbers N0254119962
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
26/09/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr G Rayman
Scientific

Ipswich Hospital NHS Trust
Heath Road
Ipswich, Suffolk
IP4 5PD
United Kingdom

Phone +44 (0)1473 704 183
Email gerry.rayman@ipswichhospital.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet.
Scientific titleThe use of local anaesthetic (Lignocaine) in fine needle biopsy of thyroid nodules
Study objectivesTo determine whether the use of 2% Lignocaine is beneficial in terms of patient acceptability/comfort and ease of operator technique, when compared with placebo (0.9% saline).
Ethics approval(s)Ethics approval was received from the local medical ethics committee before trial recruitment began
Health condition(s) or problem(s) studiedRespiratory: Pain
InterventionConsenting patients will receive either 2% Lignocaine or placebo (0.9% saline). The preparation received will be distributed by a randomised numbered system dictated by the pharmacy department of the Ipswich Hospital. Thus both patient and investigator will be blinded. Between 0.5 and 1.0 ml will be infiltrated with a 30G insulin needle under the skin immediately overlying the thyroid nodule. A period of at least 10 min and less than 20 min will be allowed to be elapsed before performing the biopsy. This will be performed using a standard technique where at least six biopsies will be attempted using a 25G needle. Patients will be asked to rate the level of discomfort experienced on a scale from between 1 and 5. The operator will also be asked to subjectively assess the ease of the procedure and his/her impression of the level of patient discomfort, again this will be rated on a scale from 1-5. The final assessment relates to the success in obtaining adequate specimens for cytological examination.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Lignocaine
Primary outcome measurePain reduction
Secondary outcome measuresNumber of aspirations attainable (up to 5) and success in obtaining adequate samples.
Overall study start date18/03/2003
Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants60 patients (30 in each group)
Key inclusion criteriaAll patients attending for fine needle aspiration of the thyroid gland to the Ipswich Hospital NHS Trust will be asked to participate.
Key exclusion criteriaPatients who have had a previous fine needle aspiration biopsy.
Date of first enrolment18/03/2003
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Ipswich Hospital NHS Trust
Ipswich, Suffolk
IP4 5PD
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

Ipswich Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

26/09/2016: No publications found, verifying study status with principal investigator